aclidinium bromide

FDA Drug Profile — Tudorza Pressair

Drug Details

Generic Name
aclidinium bromide
Brand Names
Tudorza Pressair
Application Number
NDA202450
Sponsor
Covis Pharma US, Inc
NDC Codes
1
Dosage Forms
POWDER, METERED
Routes
RESPIRATORY (INHALATION)
Active Ingredients
ACLIDINIUM BROMIDE

Indications and Usage

1 INDICATIONS AND USAGE DUAKLIR PRESSAIR is a combination of aclidinium bromide (an anticholinergic) and formoterol fumarate (a LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Limitations of Use: DUAKLIR PRESSAIR is not indicated for the relief of acute bronchospasm or for the treatment of asthma [see Warnings and Precautions ( 5.1 , 5.4 )] . DUAKLIR PRESSAIR is a combination of aclidinium bromide an anticholinergic, and formoterol fumarate, a long-acting beta 2 -adrenergic agonist (LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1 ) Limitations of Use: Not indicated for the relief of acute bronchospasm or for the treatment of asthma. ( 1 , 5.4 )